Case study of hepatitis C virus control in Egypt: impact of access program
Imam Waked
Abstract
BACKGROUND: Although Egypt was the country with the highest prevalence of hepatitis C in the world, the availability of sofosbuvir based therapies enabled Egypt to be the first country to eliminate hepatitis C and cure more than 4 million chronically infected patients. PURPOSE: This is a small tribute to John Martin. METHODOLOGY AND CONCLUSION: Here I present a summary of the HCV problem in Egypt, and how we, through Gilead's Access program under his leadership, were able to eliminate the disease.
Topics & Concepts
SofosbuvirMedicineHepatitis C virusHepatitis CTributeVirologyDisease controlDisease EradicationEnvironmental healthFamily medicineDiseaseVirusRibavirinInternal medicinePolitical scienceLawHepatitis C virus researchHepatitis B Virus StudiesLiver Disease Diagnosis and Treatment